126 related articles for article (PubMed ID: 38271566)
1. Profiling Kinase Activities for Precision Oncology in Diffuse Gastric Cancer.
Singh S; Parthasarathi KTS; Bhat MY; Gopal C; Sharma J; Pandey A
OMICS; 2024 Feb; 28(2):76-89. PubMed ID: 38271566
[TBL] [Abstract][Full Text] [Related]
2. Cancer gene profiling explores the possible precision medicine for diffuse-type gastric adenocarcinoma.
Ishikawa M; Hayashi H; Sakamoto N; Tanaka S; Nishihara H
Med Oncol; 2019 Nov; 37(1):10. PubMed ID: 31768798
[TBL] [Abstract][Full Text] [Related]
3. Multi-omics analysis identifies pathways and genes involved in diffuse-type gastric carcinogenesis induced by E-cadherin, p53, and Smad4 loss in mice.
Park JW; Kim MS; Voon DC; Kim SJ; Bae J; Mun DG; Ko SI; Kim HK; Lee SW; Kim DY
Mol Carcinog; 2018 Jul; 57(7):947-954. PubMed ID: 29528141
[TBL] [Abstract][Full Text] [Related]
4. Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers.
Cho SY; Park JW; Liu Y; Park YS; Kim JH; Yang H; Um H; Ko WR; Lee BI; Kwon SY; Ryu SW; Kwon CH; Park DY; Lee JH; Lee SI; Song KS; Hur H; Han SU; Chang H; Kim SJ; Kim BS; Yook JH; Yoo MW; Kim BS; Lee IS; Kook MC; Thiessen N; He A; Stewart C; Dunford A; Kim J; Shih J; Saksena G; Cherniack AD; Schumacher S; Weiner AT; Rosenberg M; Getz G; Yang EG; Ryu MH; Bass AJ; Kim HK
Gastroenterology; 2017 Aug; 153(2):536-549.e26. PubMed ID: 28522256
[TBL] [Abstract][Full Text] [Related]
5. Copy number alterations and epithelial‑mesenchymal transition genes in diffuse and intestinal gastric cancers in Mexican patients.
Larios-Serrato V; Martínez-Ezquerro JD; Valdez-Salazar HA; Torres J; Camorlinga-Ponce M; Piña-Sánchez P; Ruiz-Tachiquín ME
Mol Med Rep; 2022 May; 25(5):. PubMed ID: 35362543
[TBL] [Abstract][Full Text] [Related]
6. A proteomic landscape of diffuse-type gastric cancer.
Ge S; Xia X; Ding C; Zhen B; Zhou Q; Feng J; Yuan J; Chen R; Li Y; Ge Z; Ji J; Zhang L; Wang J; Li Z; Lai Y; Hu Y; Li Y; Li Y; Gao J; Chen L; Xu J; Zhang C; Jung SY; Choi JM; Jain A; Liu M; Song L; Liu W; Guo G; Gong T; Huang Y; Qiu Y; Huang W; Shi T; Zhu W; Wang Y; He F; Shen L; Qin J
Nat Commun; 2018 Mar; 9(1):1012. PubMed ID: 29520031
[TBL] [Abstract][Full Text] [Related]
7. Saracatinib impairs the peritoneal dissemination of diffuse-type gastric carcinoma cells resistant to Met and fibroblast growth factor receptor inhibitors.
Yamaguchi H; Takanashi M; Yoshida N; Ito Y; Kamata R; Fukami K; Yanagihara K; Sakai R
Cancer Sci; 2014 May; 105(5):528-36. PubMed ID: 24612061
[TBL] [Abstract][Full Text] [Related]
8. Multilevel proteomic analyses reveal molecular diversity between diffuse-type and intestinal-type gastric cancer.
Shi W; Wang Y; Xu C; Li Y; Ge S; Bai B; Zhang K; Wang Y; Zheng N; Wang J; Wang S; Ji G; Li J; Nie Y; Liang W; Wu X; Cui J; Wang Y; Chen L; Zhao Q; Shen L; He F; Qin J; Ding C
Nat Commun; 2023 Feb; 14(1):835. PubMed ID: 36788224
[TBL] [Abstract][Full Text] [Related]
9. Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer.
Shimada S; Mimata A; Sekine M; Mogushi K; Akiyama Y; Fukamachi H; Jonkers J; Tanaka H; Eishi Y; Yuasa Y
Gut; 2012 Mar; 61(3):344-53. PubMed ID: 21865403
[TBL] [Abstract][Full Text] [Related]
10. Identification of differential gene expression between intestinal and diffuse gastric cancer using cDNA microarray.
Wu CM; Lee YS; Wang TH; Lee LY; Kong WH; Chen ES; Wei ML; Liang Y; Hwang TL
Oncol Rep; 2006 Jan; 15(1):57-64. PubMed ID: 16328034
[TBL] [Abstract][Full Text] [Related]
11. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
[TBL] [Abstract][Full Text] [Related]
12. Phosphoproteomics Enables Molecular Subtyping and Nomination of Kinase Candidates for Individual Patients of Diffuse-Type Gastric Cancer.
Tong M; Yu C; Shi J; Huang W; Ge S; Liu M; Song L; Zhan D; Xia X; Liu W; Feng J; Shi W; Ji J; Gao J; Shi T; Zhu W; Ding C; Wang Y; He F; Shen L; Li T; Qin J
iScience; 2019 Dec; 22():44-57. PubMed ID: 31751824
[TBL] [Abstract][Full Text] [Related]
13. The dawn of precision medicine in diffuse-type gastric cancer.
Ooki A; Yamaguchi K
Ther Adv Med Oncol; 2022; 14():17588359221083049. PubMed ID: 35281349
[TBL] [Abstract][Full Text] [Related]
14. EXOC4 Promotes Diffuse-Type Gastric Cancer Metastasis via Activating FAK Signal.
Li H; Fu X; Zhao J; Li C; Li L; Xia P; Guo J; Wei W; Zeng R; Wu J; Sun Y; Huang L; Wang X
Mol Cancer Res; 2022 Jul; 20(7):1021-1034. PubMed ID: 35471457
[TBL] [Abstract][Full Text] [Related]
15. Destabilized adhesion in the gastric proliferative zone and c-Src kinase activation mark the development of early diffuse gastric cancer.
Humar B; Fukuzawa R; Blair V; Dunbier A; More H; Charlton A; Yang HK; Kim WH; Reeve AE; Martin I; Guilford P
Cancer Res; 2007 Mar; 67(6):2480-9. PubMed ID: 17363565
[TBL] [Abstract][Full Text] [Related]
16. Diffuse gastric cancer: Emerging mechanisms of tumor initiation and progression.
Monster JL; Kemp LJS; Gloerich M; van der Post RS
Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188719. PubMed ID: 35307354
[TBL] [Abstract][Full Text] [Related]
17. Activation of Transforming Growth Factor Beta 1 Signaling in Gastric Cancer-associated Fibroblasts Increases Their Motility, via Expression of Rhomboid 5 Homolog 2, and Ability to Induce Invasiveness of Gastric Cancer Cells.
Ishimoto T; Miyake K; Nandi T; Yashiro M; Onishi N; Huang KK; Lin SJ; Kalpana R; Tay ST; Suzuki Y; Cho BC; Kuroda D; Arima K; Izumi D; Iwatsuki M; Baba Y; Oki E; Watanabe M; Saya H; Hirakawa K; Baba H; Tan P
Gastroenterology; 2017 Jul; 153(1):191-204.e16. PubMed ID: 28390866
[TBL] [Abstract][Full Text] [Related]
18. The Case for Proteomics and Phospho-Proteomics in Personalized Cancer Medicine.
Doll S; Gnad F; Mann M
Proteomics Clin Appl; 2019 Mar; 13(2):e1800113. PubMed ID: 30790462
[TBL] [Abstract][Full Text] [Related]
19. Development of Combination Strategies for Focal Adhesion Kinase Inhibition in Diffuse Gastric Cancer.
Peng K; Zhang F; Wang Y; Sahgal P; Li T; Zhou J; Liang X; Zhang Y; Sethi N; Liu T; Zhang H; Bass AJ
Clin Cancer Res; 2023 Jan; 29(1):197-208. PubMed ID: 36278961
[TBL] [Abstract][Full Text] [Related]
20. The Lauren classification highlights the role of epithelial-to-mesenchymal transition in gastric carcinogenesis: an immunohistochemistry study of the STAT3 and adhesion molecules expression.
Susman S; Barnoud R; Bibeau F; Borrini F; Pocard M; Tomuleasa C; Sabourin JC
J Gastrointestin Liver Dis; 2015 Mar; 24(1):77-83. PubMed ID: 25822437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
